Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
80.60%
↑ 620% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
-15.49%
Historical baseline
PeriodValue
202580.60%
202416.57%
2023-21.36%
2022-60.37%
2021-13.20%
2020-76.50%
2019-24.70%
2018-48.80%
20177.60%
2016-14.71%